Model
Edge
Jazz Pharmaceuticals
JAZZ
Filing Type
10-Q
Filing Date
7/31/2024
Updated
8/1/24, 5:33 AM
Filing
10-Q
Earnings Release
Exhibits
10-Q
Q2
EX-10.2
OFFER LETTER
EX-31.1
CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
EX-31.2
CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
EX-32.1
CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350